Insider Transactions in Q4 2024 at Phreesia, Inc. (PHR)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2024
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
298
+0.25%
|
$5,066
$17.57 P/Share
|
|
Dec 31
2024
|
Yvonne Hui Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
388
+1.41%
|
$6,596
$17.57 P/Share
|
|
Dec 18
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect |
24
-0.27%
|
$600
$25.38 P/Share
|
|
Dec 18
2024
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
3,495
-2.92%
|
$83,880
$24.88 P/Share
|
|
Dec 17
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect |
61
-0.34%
|
$1,525
$25.41 P/Share
|
|
Dec 16
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect |
35
-0.39%
|
$840
$24.88 P/Share
|
|
Dec 16
2024
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
861
-0.35%
|
$21,525
$25.26 P/Share
|
|
Dec 16
2024
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
861
+0.35%
|
$3,444
$4.71 P/Share
|
|
Dec 13
2024
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
20,565
-7.81%
|
$514,125
$25.04 P/Share
|
|
Dec 13
2024
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,565
+7.24%
|
$82,260
$4.71 P/Share
|
|
Dec 11
2024
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
18,574
-7.11%
|
$464,350
$25.1 P/Share
|
|
Dec 11
2024
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,574
+6.63%
|
$74,296
$4.71 P/Share
|
|
Dec 11
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
11,853
-5.92%
|
$284,472
$24.85 P/Share
|
|
Dec 10
2024
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
25,000
-3.32%
|
$600,000
$24.09 P/Share
|
|
Dec 03
2024
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
25,447
-21.4%
|
$508,940
$20.93 P/Share
|
|
Dec 02
2024
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
15,152
-5.87%
|
$318,192
$21.01 P/Share
|
|
Dec 02
2024
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,152
+5.55%
|
$30,304
$2.03 P/Share
|
|
Oct 31
2024
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
546
+1.47%
|
$9,828
$18.29 P/Share
|
|
Oct 31
2024
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
546
+1.15%
|
$9,828
$18.29 P/Share
|
|
Oct 31
2024
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
546
+1.31%
|
$9,828
$18.29 P/Share
|
|
Oct 18
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
1,100
-0.55%
|
$22,000
$20.49 P/Share
|
|
Oct 16
2024
|
Yvonne Hui Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
423
-1.55%
|
$8,883
$21.33 P/Share
|
|
Oct 15
2024
|
Balaji Gandhi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
864
-0.88%
|
$18,144
$21.03 P/Share
|
|
Oct 15
2024
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
1,212
-1.0%
|
$25,452
$21.03 P/Share
|
|
Oct 15
2024
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,843
-0.24%
|
$38,703
$21.03 P/Share
|
|
Oct 15
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
2,011
-0.99%
|
$42,231
$21.03 P/Share
|
|
Oct 15
2024
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,089
-0.25%
|
$64,869
$21.03 P/Share
|
|
Oct 15
2024
|
Yvonne Hui Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,791
-4.69%
|
$55,820
$20.97 P/Share
|
|
Oct 15
2024
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
624
-0.52%
|
$13,104
$21.03 P/Share
|